Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate

Critical illnesses associated with coronavirus disease 2019 (COVID-19) are attributable to a hypercoagulable status. There is limited knowledge regarding the dynamic changes in coagulation factors among COVID-19 patients on nafamostat mesylate, a potential therapeutic anticoagulant for COVID-19. Fir...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thromb Thrombolysis
Main Authors: Osawa, Itsuki, Okamoto, Koh, Ikeda, Mahoko, Otani, Amato, Wakimoto, Yuji, Yamashita, Marie, Shinohara, Takayuki, Kanno, Yoshiaki, Jubishi, Daisuke, Kurano, Makoto, Harada, Sohei, Okugawa, Shu, Yatomi, Yutaka, Moriya, Kyoji
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486975/
https://ncbi.nlm.nih.gov/pubmed/32920751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02275-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares